Overview

A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus

Status:
Terminated
Trial end date:
2012-07-30
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess if CC-930 is safe and tolerable in treating subjects with Discoid Lupus Erythematosus. Pharmacokinetic and pharmacodynamics will also be evaluated.
Phase:
Phase 2
Details
Lead Sponsor:
Celgene
Celgene Corporation